Frazier Life Sciences Management, L.P. Immunocore Holdings PLC Transaction History
Frazier Life Sciences Management, L.P.
- $1.86 Billion
- Q3 2024
A detailed history of Frazier Life Sciences Management, L.P. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 108,762 shares of IMCR stock, worth $3.31 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
108,762
Previous 108,762
-0.0%
Holding current value
$3.31 Million
Previous $3.69 Million
8.14%
% of portfolio
0.18%
Previous 0.22%
Shares
1 transactions
Others Institutions Holding IMCR
# of Institutions
140Shares Held
40.8MCall Options Held
197KPut Options Held
451K-
Wellington Management Group LLP Boston, MA7.05MShares$214 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.5MShares$198 Million0.12% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$148 Million2.42% of portfolio
-
Primecap Management CO Pasadena, CA2.47MShares$75.1 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.16MShares$65.6 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.33B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...